-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Sionna Therapeutics, Maintains $58 Price Target

Benzinga·05/13/2026 09:30:29
Listen to the news
BTIG analyst Kambiz Yazdi reiterates Sionna Therapeutics (NASDAQ:SION) with a Buy and maintains $58 price target.